Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials. 2021

Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
School of Biological Sciences, Monash University, Clayton, Victoria, Australia. fernando.gordilloaltamirano@monash.edu.

We characterized two bacteriophages, ΦFG02 and ΦCO01, against clinical isolates of Acinetobacter baumannii and established that the bacterial capsule is the receptor for these phages. Phage-resistant mutants harboured loss-of-function mutations in genes responsible for capsule biosynthesis, resulting in capsule loss and disruption of phage adsorption. The phage-resistant strains were resensitized to human complement, beta-lactam antibiotics and alternative phages and exhibited diminished fitness in vivo. Using a mouse model of A. baumannii infection, we showed that phage therapy was effective.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071059 Phage Therapy Therapeutic use of BACTERIOPHAGES to treat diseases. Bacteriophage Therapy,Bacteriophage Therapies,Phage Therapies
D000073658 Loss of Function Mutation A mutation that causes a decrease in or elimination of a gene product's activity. Leaky Mutation,Null Mutation,Leaky Mutations,Mutation, Leaky,Mutation, Null,Mutations, Leaky,Mutations, Null,Null Mutations
D000151 Acinetobacter Infections Infections with bacteria of the genus ACINETOBACTER. Mimae Infections,Infections, Acinetobacter,Infections, Mimae,Acinetobacter Infection,Infection, Acinetobacter,Infection, Mimae,Mimae Infection
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
January 2019, Frontiers in microbiology,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
June 2022, Environmental microbiology reports,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
May 2024, Journal of medical microbiology,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
November 2016, Rinsho byori. The Japanese journal of clinical pathology,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
June 2007, Emerging infectious diseases,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
October 2008, Klinicka mikrobiologie a infekcni lekarstvi,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
January 2005, Emerging infectious diseases,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
September 2022, Pakistan journal of pharmaceutical sciences,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
January 2010, Medycyna doswiadczalna i mikrobiologia,
Fernando Gordillo Altamirano, and John H Forsyth, and Ruzeen Patwa, and Xenia Kostoulias, and Michael Trim, and Dinesh Subedi, and Stuart K Archer, and Faye C Morris, and Cody Oliveira, and Luisa Kielty, and Denis Korneev, and Moira K O'Bryan, and Trevor J Lithgow, and Anton Y Peleg, and Jeremy J Barr
June 2009, Emerging infectious diseases,
Copied contents to your clipboard!